awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24630685-DC4D8A5D-443F-4F68-BEB3-681D7B22866D
Q24630685-DC4D8A5D-443F-4F68-BEB3-681D7B22866D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24630685-DC4D8A5D-443F-4F68-BEB3-681D7B22866D
State of the science: an update on renal cell carcinoma
P2860
Q24630685-DC4D8A5D-443F-4F68-BEB3-681D7B22866D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24630685-DC4D8A5D-443F-4F68-BEB3-681D7B22866D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4c41f40d2840f097f1b0c4cb07d28ff248df1449
P2860
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.